日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Targeting mTOR and survivin concurrently potentiates radiation therapy in renal cell carcinoma by suppressing DNA damage repair and amplifying mitotic catastrophe

同时靶向 mTOR 和 survivin 可通过抑制 DNA 损伤修复和增强有丝分裂灾难来增强肾细胞癌的放射治疗

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:11.4
doi:10.1186/s13046-024-03079-8
Hari K Rachamala, Vijay S Madamsetty, Ramcharan S Angom, Naga M Nakka, Shamit Kumar Dutta, Enfeng Wang, Debabrata Mukhopadhyay, Krishnendu Pal
免疫
细胞生物学
肾癌
肿瘤细胞
mTOR
发表日期：2024
文献求助 收藏

Conditional, Tissue-Specific CRISPR/Cas9 Vector System in Zebrafish Reveals the Role of Nrp1b in Heart Regeneration

斑马鱼中的条件性组织特异性 CRISPR/Cas9 载体系统揭示了 Nrp1b 在心脏再生中的作用

期刊:Arteriosclerosis Thrombosis and Vascular Biology
影响因子:7.4
doi:10.1161/ATVBAHA.123.319189
Ramcharan Singh Angom, Ying Wang, Enfeng Wang, Shamit Kumar Dutta, Debabrata Mukhopadhyay
信号转导
发表日期：2023
文献求助 收藏

Targeting mTOR and Survivin Concurrently Potentiates Radiation Therapy in Renal Cell Carcinoma by Suppressing DNA Damage Repair and Amplifying Mitotic Catastrophe

同时靶向 mTOR 和 Survivin 可通过抑制 DNA 损伤修复和扩增有丝分裂灾难来增强肾细胞癌的放射治疗

期刊:
影响因子:
doi:10.21203/rs.3.rs-3770403/v1
Hari K Rachamala, Vijay S Madamsetty, Ramcharan S Angom, Naga M Nakka, Shamit Kumar Dutta, Enfeng Wang, Debabrata Mukhopadhyay, Krishnendu Pal
免疫
细胞生物学
肾癌
肿瘤细胞
mTOR
发表日期：2023
文献求助 收藏

Vascular Endothelial Growth Factor Receptor-1 Modulates Hypoxia-Mediated Endothelial Senescence and Cellular Membrane Stiffness via YAP-1 Pathways

血管内皮生长因子受体-1 通过 YAP-1 通路调节缺氧介导的内皮衰老和细胞膜僵硬

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.6
doi:10.3389/fcell.2022.903047
Ramcharan Singh Angom, Tanmay Kulkarni, Enfeng Wang, Shamit Kumar Dutta, Santanu Bhattacharya, Pritam Das, Debabrata Mukhopadhyay
信号转导
细胞生物学
其它细胞
WB
Senescence
发表日期：2022
文献求助 收藏

Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Cancer

靶向双重干预药物封装 (DIODE) 纳米制剂可改善胰腺癌的治疗

期刊:Cancers
影响因子:
doi:10.3390/cancers12051189
Vijay Sagar Madamsetty, Krishnendu Pal, Shamit Kumar Dutta, Enfeng Wang, Debabrata Mukhopadhyay
肿瘤
胰腺癌
发表日期：2020
文献求助 收藏

Synchronous inhibition of mTOR and VEGF/NRP1 axis impedes tumor growth and metastasis in renal cancer

同步抑制 mTOR 和 VEGF/NRP1 轴可抑制肾癌肿瘤生长和转移

期刊:npj Precision Oncology
影响因子:6.8
doi:10.1038/s41698-019-0105-2
Krishnendu Pal #, Vijay Sagar Madamsetty #, Shamit Kumar Dutta, Enfeng Wang, Ramcharan Singh Angom, Debabrata Mukhopadhyay
肿瘤
肾癌
mTOR
发表日期：2019
文献求助 收藏

Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC

通过肿瘤靶向脂质体制剂共同递送依维莫司和长春瑞滨可抑制肾细胞癌中的肿瘤生长和转移

期刊:International Journal of Nanomedicine
影响因子:6.6
doi:10.2147/IJN.S204221
Krishnendu Pal #, Vijay Sagar Madamsetty #, Shamit Kumar Dutta, Debabrata Mukhopadhyay
肿瘤
肾癌
肿瘤细胞
发表日期：2019
文献求助 收藏

Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive Tumors

脂溶性药物和抗 Hsp90 基因的糖皮质激素受体靶向脂质体共载：诱导药物敏感性、EMT 逆转和降低侵袭性肿瘤恶性程度的策略

期刊:Molecular Pharmaceutics
影响因子:3.2
doi:10.1021/acs.molpharmaceut.6b00230
Sujan Kumar Mondal, Sudhakar Jinka, Krishnendu Pal, Swetha Nelli, Shamit Kumar Dutta, Enfeng Wang, Ajaz Ahmad, Khalid M AlKharfy, Debabrata Mukhopadhyay, Rajkumar Banerjee
肿瘤
Goat
IgG
发表日期：2016
文献求助 收藏